Fig. 3: NAA10 is a prognostic marker of ESCA.

A Kaplan–Meier plot of overall (OS) and progress-free (PFS) survival of ESCA patients stratified by NAA10 expression level. A log rank test was used to show differences between groups. B Comparison of the NAA10 expression level between EAC and ESCC. C Kaplan–Meier plot of OS and PFS survival of EAC or ESCC patients stratified by NAA10 expression level. A log rank test was used to show differences between groups. D Kaplan–Meier plot of overall (OS) survival of ESCA patients stratified by MYC expression level. A log rank test was used to show differences between groups.